Rare diseases
Investigational molecules
Locations
Back to Sweden376 clinical trials in Gothenburg, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)SwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative treatments for various types of leukemia, including chronic lymphocytic leukemia and acute myeloid leukemia. Studies are evaluating new therapeutic combinations and treatment approaches for lymphoma and pediatric cancers.
Advanced research into targeted therapies and personalized treatment protocols for better patient outcomes.
Groundbreaking studies on rare genetic conditions including Niemann-Pick disease and gangliosidoses. Research focuses on evaluating novel treatments and investigating long-term outcomes for mucopolysaccharidosis and other rare disorders.
Innovative approaches to addressing complex rare diseases with targeted therapeutic interventions.
Comprehensive research into cardiovascular disease prevention and treatment, alongside studies on various kidney conditions. Trials evaluating new medications for stroke prevention in atrial fibrillation and treatments for glomerular diseases.
Focus on developing effective treatments for both common and rare cardiovascular and renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
